Kalbe Farma Tbk vs Multifiling Mitra Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp735 (market cap 35.34T, 108.3M 24h volume), while Multifiling Mitra Indonesia Tbk. trades at Rp1,300 (market cap 984.86B). The key difference: Kalbe Farma Tbk is far larger — about 35.9× Multifiling Mitra Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KLBF | MFMI | |
|---|---|---|
Market Cap | 35.34T | 984.86B |
Volume | 108.3M | — |
Lot | 1.08M | — |
Turnover | 80.02B | — |
Average Price | 738.89 | — |
Value | 80.02B | — |
Indicative Equilibrium Price | 735 | — |
Indicative Equilibrium Volume | 59.74K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Read more on MFMI →